Oncolytics Biotech Stock

Oncolytics Biotech P/B

The P/B (Price-to-Book Ratio) of Oncolytics Biotech (ONCY) as of Aug 12, 2026 is -17.25. In the previous year, P/B (Price-to-Book Ratio) was 21.06 — a change of -181.90% (lower).

P/B

-17.25

YoY

-181.90%

Last updated:

P/B (Price-to-Book Ratio) of Oncolytics Biotech is 2026 -17.25 . P/B (Price-to-Book Ratio) of Oncolytics Biotech was 2025 21.06 . It decreases by -181.90% lower compared to the previous year.
Access this data via the Eulerpool API

Oncolytics Biotech Stock analysis

What does Oncolytics Biotech do? Oncolytics Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oncolytics Biotech stock

P/B (Price-to-Book Ratio) of Oncolytics Biotech is -17.25 in 2026.

P/B (Price-to-Book Ratio) of Oncolytics Biotech changed from 21.06 to -17.25, representing a -181.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Oncolytics Biotech since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Oncolytics Biotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Oncolytics Biotech

All Key Metrics — Oncolytics Biotech